Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder.

ABSTRACT:

Objectives

Advances in the treatment of opioid use disorder (OUD) have seen the development of long-acting injectable opioid substitutes which could improve outcomes for people with OUD. However, comparative quantitative analysis of individual outcomes is lacking. The present study sought to investigate factors associated with prescribing long-acting injectable buprenorphine (LAIB), and changes in outcome variables compared with oral medication for OUD.

Design

Cross-sectional retrospective analysis of electronic health records.

Setting

Community substance use treatment service Via. Six sites shared their data between 15 August 2022 and 15 August 2023.

Participants

Anonymised data were extracted for 235 people receiving LAIB and 266 people receiving oral medicat

SUBMITTER: Montgomery C 

PROVIDER: S-EPMC11836814 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature